Search tips
Search criteria 


Logo of narLink to Publisher's site
Nucleic Acids Res. 1997 May 15; 25(10): 1903–1912.
PMCID: PMC146682

Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.


The mechanism by which retinoids, thyroid hormone (T3) and estrogens modulate the growth of breast cancer cells is unclear. Since nuclear type II nuclear receptors, including retinoic acid receptor (RAR), retinoid X receptor (RXR) and thyroid hormone receptor (TR), bind direct repeats (DR) of the estrogen response elements (ERE) half-site (5'-AGGTCA-3'), we examined the ability of estrogen receptor (ER) versus type II nuclear receptors, i.e. RARalpha, beta and gamma, RXRbeta, TRalpha and TRbeta, to bind various EREs in vitro . ER bound a consensus ERE, containing a perfectly palindromic 17 bp inverted repeat (IR), as a homodimer. In contrast, ER did not bind to a single ERE half-site. Likewise, ER did not bind two tandem (38 bp apart) half-sites, but low ER binding was detected to three tandem copies of the same half-site. RARalpha,beta or gamma bound both ERE and half-site constructs as a homodimer. RXRbeta did not bind full or half-site EREs, nor did RXRbeta enhance RARalpha binding to a full ERE. However, RARalpha and RXRbeta bound a half-site ERE cooperatively forming a dimeric complex. The RARalpha-RXRbeta heterodimer bound the Xenopus vitellogenin B1 estrogen responsive unit, with two non-consensus EREs, with higher affinity than one or two copies of the full or half-site ERE. Both TRalpha and TRbeta bound the full and the half-site ERE as monomers and homodimers and cooperatively as heterodimers with RXRbeta. We suggest that the cellular concentrations of nuclear receptors and their ligands, and the nature of the ERE or half-site sequence and those of its flanking sequences determine the occupation of EREs in estrogen-regulated genes in vivo .

Full Text

The Full Text of this article is available as a PDF (306K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Linney E. Retinoic acid receptors: transcription factors modulating gene regulation, development, and differentiation. Curr Top Dev Biol. 1992;27:309–350. [PubMed]
  • Giguère V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev. 1994 Feb;15(1):61–79. [PubMed]
  • Moon RC, Mehta RG. Chemoprevention of mammary cancer by retinoids. Basic Life Sci. 1990;52:213–224. [PubMed]
  • Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagne D. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res. 1994 Mar 15;54(6):1458–1464. [PubMed]
  • Love-Schimenti CD, Gibson DF, Ratnam AV, Bikle DD. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. Cancer Res. 1996 Jun 15;56(12):2789–2794. [PubMed]
  • Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A, et al. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res. 1995 Oct 1;55(19):4446–4451. [PubMed]
  • Lehmann JM, Dawson MI, Hobbs PD, Husmann M, Pfahl M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res. 1991 Sep 15;51(18):4804–4809. [PubMed]
  • Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. [PubMed]
  • Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 1992 Apr 15;52(8):2236–2242. [PubMed]
  • Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 1986 Sep 26;46(7):1053–1061. [PubMed]
  • Berry M, Nunez AM, Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1218–1222. [PubMed]
  • Walker P, Germond JE, Brown-Luedi M, Givel F, Wahli W. Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. Nucleic Acids Res. 1984 Nov 26;12(22):8611–8626. [PMC free article] [PubMed]
  • Richard S, Zingg HH. The human oxytocin gene promoter is regulated by estrogens. J Biol Chem. 1990 Apr 15;265(11):6098–6103. [PubMed]
  • Martinez E, Givel F, Wahli W. The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element. EMBO J. 1987 Dec 1;6(12):3719–3727. [PubMed]
  • Kraus WL, Montano MM, Katzenellenbogen BS. Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol Endocrinol. 1994 Aug;8(8):952–969. [PubMed]
  • Weisz A, Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 1990 Sep 11;18(17):5097–5106. [PMC free article] [PubMed]
  • Martinez E, Wahli W. Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 1989 Dec 1;8(12):3781–3791. [PubMed]
  • Klein-Hitpass L, Kaling M, Ryffel GU. Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential. J Mol Biol. 1988 Jun 5;201(3):537–544. [PubMed]
  • Kato S, Sasaki H, Suzawa M, Masushige S, Tora L, Chambon P, Gronemeyer H. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol. 1995 Nov;15(11):5858–5867. [PMC free article] [PubMed]
  • Aumais JP, Lee HS, DeGannes C, Horsford J, White JH. Function of directly repeated half-sites as response elements for steroid hormone receptors. J Biol Chem. 1996 May 24;271(21):12568–12577. [PubMed]
  • Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996 Oct;10(10):1167–1177. [PubMed]
  • Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995 Dec 15;83(6):841–850. [PubMed]
  • Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature. 1992 Jan 30;355(6359):441–446. [PubMed]
  • Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994 Jun;15(3):391–407. [PubMed]
  • Glass CK, Holloway JM, Devary OV, Rosenfeld MG. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell. 1988 Jul 29;54(3):313–323. [PubMed]
  • Segars JH, Marks MS, Hirschfeld S, Driggers PH, Martinez E, Grippo JF, Brown M, Wahli W, Ozato K. Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways. Mol Cell Biol. 1993 Apr;13(4):2258–2268. [PMC free article] [PubMed]
  • Nunez SB, Medin JA, Keller H, Wang K, Ozato K, Wahli W, Segars J. Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element. Recent Prog Horm Res. 1995;50:409–416. [PubMed]
  • Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 1992 Jan 24;68(2):377–395. [PubMed]
  • Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 Jan 30;355(6359):446–449. [PubMed]
  • Marks MS, Levi BZ, Segars JH, Driggers PH, Hirschfeld S, Nagata T, Appella E, Ozato K. H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements. Mol Endocrinol. 1992 Feb;6(2):219–230. [PubMed]
  • Segars JH, Marks MS, Hirschfeld S, Driggers PH, Martinez E, Grippo JF, Brown M, Wahli W, Ozato K. Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways. Mol Cell Biol. 1993 Apr;13(4):2258–2268. [PMC free article] [PubMed]
  • Sharif M, Privalsky ML. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell. 1991 Sep 6;66(5):885–893. [PubMed]
  • Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagne D. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res. 1994 Mar 15;54(6):1458–1464. [PubMed]
  • Peale FV, Jr, Ludwig LB, Zain S, Hilf R, Bambara RA. Properties of a high-affinity DNA binding site for estrogen receptor. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1038–1042. [PubMed]
  • Klinge CM, Peale FV, Jr, Hilf R, Bambara RA, Zain S. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res. 1992 Mar 1;52(5):1073–1081. [PubMed]
  • Anolik JH, Klinge CM, Bambara RA, Hilf R. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J Steroid Biochem Mol Biol. 1993 Dec;46(6):713–730. [PubMed]
  • Anolik JH, Klinge CM, Hilf R, Bambara RA. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry. 1995 Feb 28;34(8):2511–2520. [PubMed]
  • Pavlik EJ, Coulson PB. Hydroxylapatite "batch" assay for estrogen receptors: increased sensitivity over present receptor assays. J Steroid Biochem. 1976 May;7(5):357–368. [PubMed]
  • Quick TC, Traish AM, Niles RM. Characterization of human retinoic acid receptor alpha 1 expressed in recombinant baculovirus-infected Sf9 insect cells. Receptor. 1994 Summer;4(2):65–80. [PubMed]
  • Ludwig LB, Klinge CM, Peale FV, Jr, Bambara RA, Zain S, Hilf R. A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. Mol Endocrinol. 1990 Jul;4(7):1027–1033. [PubMed]
  • Klinge CM, Traish AM, Bambara RA, Hilf R. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA. J Steroid Biochem Mol Biol. 1996 Jan;57(1-2):51–66. [PubMed]
  • Klinge CM, Traish AM, Driscoll MD, Hilf R, Bambara RA. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro. Steroids. 1996 May;61(5):278–289. [PubMed]
  • Traish AM, Wotiz HH. Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors. Endocrinology. 1990 Sep;127(3):1167–1175. [PubMed]
  • Hoopes BC, LeBlanc JF, Hawley DK. Kinetic analysis of yeast TFIID-TATA box complex formation suggests a multi-step pathway. J Biol Chem. 1992 Jun 5;267(16):11539–11547. [PubMed]
  • Tzeng DZ, Klinge CM. Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability. Biochem Biophys Res Commun. 1996 Jun 25;223(3):554–560. [PubMed]
  • Anolik JH, Klinge CM, Brolly CL, Bambara RA, Hilf R. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors. J Steroid Biochem Mol Biol. 1996 Dec;59(5-6):413–429. [PubMed]
  • Abbondanza C, de Falco A, Nigro V, Medici N, Armetta I, Molinari AM, Moncharmont B, Puca GA. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids. 1993 Jan;58(1):4–12. [PubMed]
  • Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, Nicolas B, Andre J. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Endocrinology. 1992 Mar;130(3):1145–1152. [PubMed]
  • de Launoit Y, Kiss R. Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells. In Vitro Cell Dev Biol. 1989 Jul;25(7):585–591. [PubMed]
  • Klinge CM, Bambara RA, Hilf R. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. J Steroid Biochem Mol Biol. 1992 Oct;43(4):249–262. [PubMed]
  • Qiu Y, Krishnan V, Pereira FA, Tsai SY, Tsai MJ. Chicken ovalbumin upstream promoter-transcription factors and their regulation. J Steroid Biochem Mol Biol. 1996 Jan;56(1-6):81–85. [PubMed]
  • Rhodes D, Klug A. Helical periodicity of DNA determined by enzyme digestion. Nature. 1980 Aug 7;286(5773):573–578. [PubMed]
  • Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol. 1992 Mar;6(3):429–442. [PubMed]
  • Suva LJ, Towler DA, Harada S, Gaub MP, Rodan GA. Characterization of retinoic acid- and cell-dependent sequences which regulate zif268 gene expression in osteoblastic cells. Mol Endocrinol. 1994 Nov;8(11):1507–1520. [PubMed]
  • Perlmann T, Rangarajan PN, Umesono K, Evans RM. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 1993 Jul;7(7B):1411–1422. [PubMed]
  • Zechel C, Shen XQ, Chambon P, Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J. 1994 Mar 15;13(6):1414–1424. [PubMed]
  • Nagpal S, Friant S, Nakshatri H, Chambon P. RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J. 1993 Jun;12(6):2349–2360. [PubMed]
  • Shulemovich K, Dimaculangan DD, Katz D, Lazar MA. DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR. Nucleic Acids Res. 1995 Mar 11;23(5):811–818. [PMC free article] [PubMed]
  • Thompson KL, Santon JB, Shephard LB, Walton GM, Gill GN. A nuclear protein is required for thyroid hormone receptor binding to an inhibitory half-site in the epidermal growth factor receptor promoter. Mol Endocrinol. 1992 Apr;6(4):627–635. [PubMed]
  • Reginato MJ, Zhang J, Lazar MA. DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor. J Biol Chem. 1996 Nov 8;271(45):28199–28205. [PubMed]
  • Tini M, Tsui LC, Giguère V. Heterodimeric interaction of the retinoic acid and thyroid hormone receptors in transcriptional regulation on the gamma F-crystallin everted retinoic acid response element. Mol Endocrinol. 1994 Nov;8(11):1494–1506. [PubMed]
  • Joyeux A, Balaguer P, Gagne D, Nicolas JC. In vitro and in vivo interactions between nuclear receptors at estrogen response elements. J Steroid Biochem Mol Biol. 1996 Aug;58(5-6):507–515. [PubMed]
  • När AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK, Rosenfeld MG. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell. 1991 Jun 28;65(7):1267–1279. [PubMed]
  • Driscoll MD, Klinge CM, Hilf R, Bambara RA. Footprint analysis of estrogen receptor binding to adjacent estrogen response elements. J Steroid Biochem Mol Biol. 1996 Apr;58(1):45–61. [PubMed]
  • Claret FX, Antakly T, Karin M, Saatcioglu F. A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha. Mol Cell Biol. 1996 Jan;16(1):219–227. [PMC free article] [PubMed]
  • Williams GR, Harney JW, Moore DD, Larsen PR, Brent GA. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors. Mol Endocrinol. 1992 Oct;6(10):1527–1537. [PubMed]
  • Seiler-Tuyns A, Walker P, Martinez E, Mérillat AM, Givel F, Wahli W. Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. Nucleic Acids Res. 1986 Nov 25;14(22):8755–8770. [PMC free article] [PubMed]
  • Sucov HM, Murakami KK, Evans RM. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5392–5396. [PubMed]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press